Trustmark National Bank Trust Department’s Core Laboratories CLB Stock Holding History

Trustmark National Bank Trust Department’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,631	Closed	-$202K	–	270
2016 Q2	$202K	Sell	1,631 -622	-28%	-$75.1K	0.03%	275
2016 Q1	$254K	Buy	2,253 +148	+7%	+$15.4K	0.03%	258
2015 Q4	$229K	Buy	2,105 +43	+2%	+$4.92K	0.03%	285
2015 Q3	$206K	Buy	+2,062	New	+$224K	0.03%	324

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

Trustmark National Bank Trust Department's CLB Position: Q3 2016 in Review

Trustmark National Bank Trust Department sold out of Core Laboratories (CLB) in Q3 2016, closing a stake of 1,631 shares — an estimated $202K sold.

Trustmark National Bank Trust Department first reported a position in CLB in Q3 2015 and held it in 4 quarters. The position peaked at $254K in Q1 2016. 374 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

Trustmark National Bank Trust Department reported no remaining Core Laboratories position as of Q3 2016 after selling out during the quarter.
Trustmark National Bank Trust Department sold 1,631 Core Laboratories shares in Q3 2016, an estimated $202K.
Trustmark National Bank Trust Department first reported a position in Core Laboratories in Q3 2015 and held it in 4 quarters.
Trustmark National Bank Trust Department's Core Laboratories position peaked at $254K in Q1 2016.
374 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on Trustmark National Bank Trust Department's 13F filing for Q3 2016, filed 10 Nov 2016.